Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Still a Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up prior to trading on Friday . The stock had previously closed at $18.20, but opened at $18.90. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $18.89, with a volume of 5,270 shares changing hands.

Wall Street Analysts Forecast Growth

Several research firms recently commented on TLX. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group raised their price target on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The company has a 50-day moving average of $16.08.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.